Establishes a grant program to fund drug development trials for ibogaine to treat opioid use disorder and other conditions.
The bill establishes a grant program to fund drug development trials for ibogaine, a potential treatment for opioid use disorder, co-occurring substance use disorder, and other neurological or mental health conditions. The Secretary of Health will administer the program, which includes issuing a notice of funding opportunity, selecting applicants, and establishing drug development trial sites. Applicants must submit an investigational new drug application to the FDA and seek a breakthrough therapy designation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.